IDEAYA Biosciences (IDYA) stock jumped 26% after its eye cancer drug combo doubled progression-free survival in a Phase 2/3 trial versus standard care.

Our BD Excellence operating model helped to drive strong P&L leverage throughout the year with adjusted gross margin up 140 ...

Commit matching funds to the KC BioHub’s next federal application. Develop targeted incentives that match Missouri’s. | Opinion ...

Shares of PMGC Holdings Inc. ELAB are trading higher on Monday after the company announced one of its subsidiaries, ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

CALGARY, AB, April 16, 2026 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a leading Canadian branded cannabis ...

The British Heart Foundation (BHF) has awarded £7.1M funding to a unique national training programme that will tackle one of the most urgent ...

IDEAYA Biosciences Inc. IDYA shares are up during Monday’s premarket session following the announcement of positive topline results from the Phase 2/3 trial for darovasertib in combination with ...

DJI has officially pulled the curtain back on the highly anticipated Osmo Pocket 4, delivering a refined pocket-sized design that promises cinematic visuals without the cumbersome bulk of a ...

Apple's new Macbook Neo outperforms expectations sending it into a supply crunch as the A18 Pro's availability continues to pose a challenge.

Late in the afternoon Eastern Time on Oct. 7, 2023, after reporting revealed that invading Iran-backed Hamas jihadists had ...

Continuing a battle that has spanned three decades, multi-time USAC champion Tony Hunt prevailed over close rival Shauna Hogg ...